Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole Pharmacodynamics in Early-Stage NSCLC
NCT02357836Phase 1Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2015
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of itraconazole in non-small cell lung cancer (NSCLC), sponsored by UT Southwestern Medical Center. Primary endpoint: Tumor Tissue Microvessel Density. Started Jun 2015; status: completed.
02
Drugs
itraconazole
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02357836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357836.